Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2014 Jun 12;5:271. doi: 10.3389/fimmu.2014.00271

HP-1γ Controls High-Affinity Antibody Response to T-Dependent Antigens

Ngoc Ha 1,, Duc-Hung Pham 2,, Aliakbar Shahsafaei 3, Chie Naruse 4, Masahide Asano 4, To-Ha Thai 1,*
PMCID: PMC4053855  PMID: 24971082

Abstract

In vitro observations suggest a role for the mouse heterochromatin protein 1γ (HP-1γ) in the immune system. However, it has not been shown if and how HP-1γ contributes to immunity in vivo. Here we show that in mice, HP-1γ positively regulates the germinal center reaction and high-affinity antibody response to thymus (T)-dependent antigens by limiting the size of CD8+ regulatory T-cell (Treg) compartment without affecting progenitor B- or T-cell-development. Moreover, HP-1γ does not control cell proliferation or class switch recombination. Haploinsufficiency of cbx-3 (gene encoding HP-1γ) is sufficient to expand the CD8+ Treg population and impair the immune response in mice despite the presence of wild-type HP-1α and HP-1β. This is the first in vivo evidence demonstrating the non-redundant role of HP-1γ in immunity.

Keywords: chromatin remodeling, epigenetics, adaptive immunity, germinal center response, CD8+ regulatory T cells

Introduction

The adaptive immune system allows jawed vertebrates to distinguish self from non-self, to eliminate infectious agents, and to eradicate tumors. In addition, jawed vertebrates have the unique ability to store long-term immunological memory, thus enabling a rapid and vigorous adaptive immune response against previously encountered microbes. To achieve this outcome, diverse lymphocyte populations and their effector functions must be finely orchestrated and controlled. Dysregulation of any of these processes may result in the development of autoimmune diseases, inability to resolve infections, or failure to control the outgrowth of malignant cells. Therefore, the regulation of the adaptive immune response must occur on many levels, and there still remain novel genes and pathways yet to be uncovered.

The heterochromatin protein 1 (HP-1) family includes members that associate with modified histones, indicating that HP-1 proteins are involved in epigenetic modifications. HP-1 proteins are conserved from the yeast Schizosaccharomyces pombe (S. pombe) to mammals (15). The mammalian HP-1 family consists of three conserved members: HP-1α, HP-1β, and HP-1γ encoded by cbx-5, cbx-1, and cbx-3, respectively (2). Of particular significance to the immune system is the observation that HP-1γ is found associated with the transcription elongation complex containing RNA polymerase II (Pol II) within the coding region of the actively transcribed IL-2 gene in stimulated primary T cells (6). By contrast, during B-cell-development, HP-1γ associates with the silenced κ allele implicating HP-1γ in allelic exclusion (7). In addition, HP-1γ has been found associated with both heterochromatin and euchromatin suggesting that it participates in transcriptional repression and activation, respectively (4, 8, 9). HP-1γ interacts with the methyl groups of H3K9 through the chromodomain (CD) and with the methyl transferase SUV39-H1 and other proteins through the chromoshadow domain (CSD) (2, 3, 10). Despite these crucial in vitro observations, it is not understood if and how HP-1γ contributes to the regulation of immunity in mammals in vivo. Our interest in HP-1γ stems from efforts to identify novel targets of miR-155 (11). We find that HP-1γ expression is induced in activated mutant B cells suggesting that it might be an miR-155 target.

During a thymus (T)-dependent B-cell response, activated B cells migrate into follicles of secondary lymphoid organs. A fraction of activated B cells mediate a primary antibody (Ab) response through differentiation into plasma cells, others are recruited to the germinal center (GC) reaction (12, 13). In the GC, a specialized structure within the follicle, B cells undergo massive proliferation accompanied by class switch recombination (CSR) and somatic hypermutation (SHM) of rearranged immunoglobulin (Ig) V region genes. SHM leads to the acquisition of mutations that increase Ab affinity to the immunizing antigen (Ag), a process known as affinity maturation (12, 14, 15). The production of high-affinity, isotype-switched Ab is crucial for the clearance of many infectious pathogens and provides the basis for humoral immunity and vaccine efficacy.

Resident GC T follicular helper (TFH) cells make up a specialized subset of effector CD4+ T cells that are pivotal in affinity maturation by selecting activated B cells to enter the GC, regulating GC positive selection, and directing B-cell differentiation to plasma cells and memory B cells (1618). Within the GC, TFH cells develop in concert with GC B cells (1924).

Early observations show that a subset of effector CD8+ T cells can suppress T-cell help to B cells (25). Recent studies demonstrate that these CD8+ regulatory T (Treg) cells control GC reaction and high-affinity Ab response to foreign T-dependent Ags as well as self-Ags by limiting the size of the TFH compartment (26, 27). In mice, genetic disruption of the inhibitory interaction between CD8+ Treg cells and their target Qa-1+ TFH cells results in the development of systemic lupus erythematosus (SLE)-like autoimmune disease and the inability to mount a high-affinity Ab response to T-dependent Ags. These studies reveal the central role that CD8+ Treg cells play in the control of the adaptive immune response. However, mechanisms that regulate the development and/or homeostasis of these cells remain elusive.

In this study, we uncover a novel molecular pathway that regulates the adaptive immune response to T-dependent Ags. We demonstrate that HP-1γ positively controls the GC reaction and high-affinity Ab response. HP-1γ does so by limiting the size of the CD8+ Treg compartment. Haploinsufficiency of cbx-3 results in the expansion of CD8+ Treg cells and impaired immune response.

Results

B- or T-cell-development is not affected by HP-1γ deficiency

Although in vitro studies suggest a role for HP-1γ in the immune system, it has not been determined if it contributes to immunity in vivo. The cbx-3 (gene encoding HP-1γ) mutant mouse was generated by gene-trapping technology as described previously (10, 28). We found that cbx-3/− mice died perinatally. Because haploinsufficiency of genes involved in epigenetic modifications has been shown to alter cellular functions (29), we asked if haploinsufficiency of cbx-3 was sufficient to affect the immune system. First we assessed if cbx-3 deficiency influenced progenitor lymphoid development. A survey of the bone marrow (BM) and thymus showed that progenitor B and T cells developed normally in cbx-3+/− mice compared to littermate controls (Figures 1A,B). Mature B- and T-cell-development also remained normal in cbx-3+/− mice (Figures 1C,D). Thus, HP-1γ is not required for progenitor or mature B- and T-cell-development.

Figure 1.

Figure 1

B- or T-cell-development is not affected by HP-1γ deficiency. (A) Bone marrow progenitor B-cell development from unimmunized wt littermate and cbx-3+/− mice was determined by FACS. Progenitor B cells were gated on the lymphoid population. Pre-B cells were derived from the surface IgM (sIgM) negative lymphoid gate. (B) Thymi from unimmunized wt littermate and cbx-3+/− mice were analyzed to assess progenitor T-cell-development. Upper plots were derived from the lymphoid gate; lower plots were gated on the CD4CD8 population. (C) All plots were gated on CD19+ lymphoid population. Frequency of mature (IgDhiIgMlo), marginal zone (CD21hiCD23lo), and follicular (CD21loCD23hi) spleen B cells was determined by FACS. (D) Lymphoid cells from peripheral lymph nodes (pLNs) were gated on the CD3+ population, and analyzed to assess the development of mature CD4+ and CD8+ T cells. Results are representative of three independent experiments with n = 6 of each genotype.

HP-1γ deficiency results in impaired germinal center reaction

To determine the physiological function of HP-1γ in the adaptive immune response in mice, we immunized littermate control and cbx-3+/− mice with the T-dependent Ag 4-hydroxy-3-nitrophenylacetyl hapten conjugated to chicken gamma globulin (NP-CGG) in alum. On day 14 after immunization, the expected frequency of spleen B220+CD38lo/FAS+ GC as well as switched B220+CD38lo∕−IgG1+ B cells was obtained from littermate controls, demonstrating that the GC reaction occurred normally (Figure 2). In contrast, the GC response was impaired in cbx-3+/− mice. On day 14, the percent of spleen GC B cells in cbx-3+/− mice decreased by 2.3-fold compared to control mice (p = 0.0002, Figures 2A,B,F). Correspondingly, there was a twofold reduction in the percent of switched IgG1+ spleen B cells in cbx-3+/− mice compared to control mice (p = 0.0007, Figures 2A,C). Similarly, the frequency of IgG1+ GC B cells in cbx-3+/− mice was reduced by 2.8-fold compared to wild-type littermate mice (Figures 2D,E, p < 0.0001). The spleen architecture of wt littermate and mutant mice remained intact; and more peanut agglutinin (PNA) positive GCs were detected in wt littermate mice than in mutant mice on day 14 after immunization with NP (Figure 2F). These results demonstrate that HP-1γ positively regulates the GC reaction and production of IgG1+ B cells, and haploinsufficiency of cbx-3 is sufficient to impair these processes. The defect cannot be compensated for by the presence of wild-type HP-1α and HP-1β in cbx-3+/− mice suggesting that HP-1γ has a non-redundant function in immunity in vivo.

Figure 2.

Figure 2

Heterochromatin protein 1γ deficiency results in impaired germinal center reaction. (A) Wt littermate and cbx-3+/− mice were immunized with NP-CGG in alum. On day 14 after immunization, mice were analyzed by FACS to determine the frequency of spleen CD38lo/−FAS+ GC and switched CD38lo∕−IgG1+ B cells from the B220+ gate. Numbers in left bottom corners indicate percent cells. (B) Plot depicts the compilation of GC B-cell frequency from experiments in (A). Each symbol represents an individual mouse. Bars represent median ***p = 0.0002. (C) Plot summarizes switched IgG1 B-cell frequency from experiments in (A). Bars represented median ***p = 0.0007. Each symbol represents an individual mouse. (D) Frequency of IgG1+ GC B cells was determined from (A), gated on B220+CD38lo/−FAS+ GC B cells. Numbers in left bottom corners indicate percent cells. (E) Plot summarizes the percent IgG1+ GC B cells from (D). Bars represent median, ****p < 0.0001. Each symbol represents an individual mouse. (F) Immunohistochemistry of spleen sections from unimmunized and day 14 NP-immunized mice were stained for PNA (brown) to detect GCs (arrow). Spleens were from mice in (A). Images are shown at 100× magnification. Statistical analysis was performed with GraphPad one-way ANOVA. N = 8–12 for each genotype.

Cbx-3+/− mice fail to mount high-affinity NP antibody response

To determine if the diminished GC reaction in cbx-3+/− mice results in defective serum anti-NP Ab response, we measured anti-NP activity in sera obtained from cbx-3+/− and wt littermate mice on day 14 after NP immunization. Serum high- and low-affinity responses to NP can be measured by enzyme-linked immunosorbent assay (ELISA) using NP4 and NP25 Ags, respectively. On day 14 after immunization, serum IgG anti-NP25 Ab activity increased in littermate control and mutant mice compared to unimmunized animals, and the level was similar between the two groups. By contrast, the amount of serum anti-NP4 antibodies in littermate control mice was 4.75-fold higher than cbx-3+/− mice (p = 0.006, Figure 3A). Accordingly, the ratio of NP4/NP25 Ab titer was threefold lower in cbx-3+/− mice compared to littermate control mice (p = 0.02, Figure 3B). The low-affinity response was not affected by cbx-3 haploinsufficiency. Both littermate control and mutant mice produced low amounts of serum IgM Abs against NP, and the majority of IgM antibodies were of low-affinity (Figures 3C,D). There was no difference in the production of total pre-immune serum IgG1 and IgM between wt littermate control and mutant mice (Figure 3E). Thus cbx-3+/− mice could not mount high-affinity Ab response to NP.

Figure 3.

Figure 3

Cbx-3+/− mice fail to mount the high-affinity NP antibody response. (A) ELISA analysis was carried out to measure high-affinity IgG1 anti-NP4-BSA and total IgG1 anti-NP25-BSA antibody activity in sera from mice immunized with NP-CGG in alum. Each symbol represents an individual mouse. Bars represent median. Statistical analysis was performed with GraphPad one-way ANOVA. Day 14, n = 9 for each genotype, ***p = 0.006. (B) High-affinity serum IgG1 anti-NP Ab activity was determined by calculating the ratio of anti-NP4/NP25, *p = 0.02. (C) Serum IgM anti-NP4 and anti-NP25 antibody activity was analyzed by ELISA to NP-BSA as in (A). (D) Plot depicts ratio of IgM anti-NP4 over anti-NP25. (E) Total serum IgG1 and IgM titers of pre-immune sera from (A) were measured by ELISA.

HP-1γ does not regulate B-cell proliferation or class switch recombination

To rule out the possibility that reduced GC and Ab responses resulted from defects in proliferation or class switching after Ag encounter, we carried out in vitro proliferation/switch assays. Spleen B cells from cbx-3+/− mice proliferated and switched as well as littermate control B cells when activated through the B-cell receptor, Toll-like receptor (TLR) 4, or CD40 plus IL-4 (Figures 4A,B). Therefore, HP-1γ deficiency results specifically in impaired high-affinity, not total NP Ab response. HP-1γ does not control the IgM response to NP. Because HP-1γ deficiency does not perturb proliferation or switching, the defect in high-affinity Ab response observed in cbx-3+/− mice implies that HP-1γ may regulate Ab affinity maturation.

Figure 4.

Figure 4

Heterochromatin protein 1γ does not regulate B-cell proliferation or class switch recombination. (A) Naïve spleen B cells were labeled with CFSE and stimulated with various stimuli for 3 days. Cell division was determined using the FlowJo Proliferation Platform software. (B) IgG1 switching was determined from the same cultures as in (A). Results are representative of three independent experiments with six mice per genotype. Analysis was performed on cells derived from the live gate.

The T follicular helper cell population is reduced in Cbx-3+/− mice

T follicular helper cells play a crucial role in affinity maturation in part by selecting B cells to enter the GC, regulating GC positive selection, and directing B-cell differentiation to plasma cells and memory B cells. Hence, the high-affinity Ab response defect seen in cbx-3+/− mice may arise from inefficient TFH support. Fluorescence-activated cell sorting (FACS) analysis showed that as the immune response proceeded to day 14, the frequency of TCRβ+CD4+CXCR5hiPD-1hi TFH cells decreased by 1.7-fold in cbx-3+/− mice compared to wt littermate control mice (p < 0.0001, Figures 5A,B). Moreover, we did not detect any differences in Bcl6, Prdm1, or Aicda expression between wt littermate control and mutant mice suggesting that GC and plasma cell differentiation was not affected by HP-1γ deficiency (data not shown). Thus, HP-1γ governs Ab affinity maturation perhaps by controlling the size of the TFH-cell compartment during an immune response to T-dependent Ags.

Figure 5.

Figure 5

The T follicular helper cell copulation is reduced in cbx-3+/− mice. (A) The frequency of spleen TCRβ+CD4+CXCR5hiPD-1hi TFH population was determined by FACS analysis. Numbers in right bottom corners indicate the percent cells. CXCR5hiPD-1hi TFH cells were gated on the TCRβ+CD4+ population. (B) Plot represents a compilation of the percent of TFH population from (A). Each symbol denotes an individual mouse. Bars represent median. Statistical analysis was performed with GraphPad one-way ANOVA. Day 14, n = 8–12 for each genotype, ****p < 0.0001.

The GC reaction defect in Cbx-3+/− mice is not intrinsic to B or TFH cells

To determine if TFH cells were directly responsible for the GC phenotype observed, we generated cbx-3+/+/cbx-3+/− mixed BM chimeras. Recombinase activating gene 2 and common γ chain double knock out (B6-Rag2−/−−/−) mice were reconstituted with a 1:1 mix of either CD45.1 cbx-3+/+/CD45.2 cbx-3+/+ or CD45.1 cbx-3+/+/CD45.2 cbx-3+/− BM. Eight weeks after reconstitution chimeric mice were immunized with NP-CGG in alum. On day 14 after immunization, mice were analyzed to determine the frequency of GC B cells, switched IgG1+ B cells and TFH cells derived from CD45.2 (control cbx-3+/+ or cbx-3+/−) donor BM in each mouse (Figure 6A). FACS analysis showed that CD45.2 cbx-3+/+ and CD45.2 cbx-3+/− chimeric mice had similar percentage of GC and IgG1+ B cells as well as TFH cells (Figure 6B). Therefore, the GC defect observed in cbx-3+/− is not intrinsic to B or TFH cells.

Figure 6.

Figure 6

The GC reaction defect in Cbx-3+/− mice is not intrinsic to B or TFH cells. (A) cbx-3+/+/cbx-3+/− mixed bone marrow chimeras were generated in B6-Rag2//recipients at a 1:1 ratio of either CD45.1 cbx-3+/+/CD45.2 cbx-3+/+ or CD45.1 cbx-3+/+/CD45.2 cbx-3+/− bone marrow. Eight weeks after reconstitution chimeric mice were immunized with NP-CGG in alum. (B) On day 14, spleens were analyzed to determine the frequency of GC B cells, switched IgG1+ B cells and TFH cells derived from CD45.2 (control cbx-3+/+ or cbx-3+/−) donor bone marrow in each mouse. Numbers in bottom left corners of FACS plots indicate percent GC B cells. Numbers in bottom right corners denote percent TFH cells. CD45.1 and CD45.2 populations were derived from the lymphoid gate. GC and IgG1+ B cells were derived from the B220+ gate. CXCR5hiPD-1hi TFH cells were gated on the TCRβ+CD4+ population.

CD122+Ly49+CD3+CD8+ regulatory T-cell compartment is expanded in Cbx-3+/− mice

Recently, Kim and colleagues showed that CD122+Ly49+CD3+ CD8+ regulatory T (Treg) cells served to inhibit the expansion of TFH population during an immune response to foreign Ags as well as to self-Ags (26, 27). Thus it is plausible that reduction in the TFH compartment in cbx-3+/− mice may be due to an increase in CD8+ Treg cells within the CD8+ T-cell compartment. On days 7 and 14 after immunization, compared to wt littermate mice, cbx-3+/− mice had 2.3- and 1.8-fold higher frequency of spleen CD8+ Treg cells, respectively (p < 0.0001, Figures 7A,B). Correspondingly, the number of spleen CD8+ Treg cells in cbx-3+/− mice increased by 1.8- and 1.75-fold on days 7 and 14, respectively (p < 0.0001, Figure 7C). Next, western blots were carried out to assess the expression status of HP-1γ in mutant CD8+ T cells. To our surprise, CD8+ and CD4+ T cells as well as B cells from cbx-3+/− mice expressed much less HP-1γ than control cells despite the presence of one wild-type allele (Figure 7D). To ensure that the expansion of CD8+ Treg cells in cbx-3+/− mice was intrinsic to the CD8+ T-cell population, mixed BM chimeras were generated as described in Figure 6A. Mice were allowed to reconstitute for 8 weeks. On day 14 after immunization, reconstituted mice were analyzed to assess the frequency of Treg cells derived from CD45.2 (control cbx-3+/+ or cbx-3+/−) donor BM in each mouse. As shown in Figure 7E, CD45.2 cbx-3+/− chimeric mice had 4.6-fold more CD8+ Treg cells than CD45.2 cbx-3+/+ control mice. Thus, the CD8+ Treg population expanded in cbx-3+/− mice. These results suggest that HP-1γ limits the size of CD8+ Treg cells during an immune response, and the effects are intrinsic to these cells.

Figure 7.

Figure 7

CD122+Ly49+CD3+CD8+ regulatory T-cell compartment is expanded in cbx-3+/− mice. (A) On days 7 and 14 after immunization, percent of spleen CD122+Ly49+CD3+CD8+ regulatory T-cell (Treg) population from wt littermate and cbx-3+/− mice was assessed by FACS. Numbers in lower right corners indicate percent cells. CD122+Ly49+CD8+ Treg cells were gated on the CD3+ population. (B,C) Plots represent a compilation of the percent and number of CD8+ Treg population from (A). Each symbol denotes an individual mouse. Bars represent median. Statistical analysis was performed with GraphPad one-way ANOVA. Day 7, n = 5 for each genotype; ****p < 0.0001. Day 14, n = 8–12 for each genotype; ****p < 0.0001. (D) Purified CD8+CD44, CD4+CD25, and CD43 B cells were collected from spleen and peripheral lymph nodes. Blots were probed with anti-total HP-1γ (22 kDa) and anti-β-actin (42 kDa). Results are representative of two independent experiments; n = 4 mice of each genotype. (E) cbx-3+/+/cbx-3+/− mixed bone marrow chimeras were generated as in Figure 6A. Percent CD8+ Treg cells were determined by FACS. Numbers in lower right corners indicate percent cells. CD45.1 and CD45.2 populations were derived from the lymphoid gate. CD122+Ly49+CD8+ Treg cells were gated on the CD3+ population.

Cbx-3+/− CD8+ regulatory T cells directly control T-dependent immune response

To investigate if CD8+ Treg cells from cbx-3+/− mice directly controlled the Ab response, adoptive transfers into B6-Rag2−/−−/−recipients were performed. Group 1 (control) recipients received B cells, CD4+ and CD8+ T cells from wt littermate mice; group 2 (experimental) received B cells and CD4+ T cells from wt littermate mice, and CD8+ T cells from cbx-3+/− mice; group 3 (control) received B cells and CD8+ T cells from wt littermate mice, and CD4+ T cells from cbx-3+/− mice (Figure 8A). On day 10 after immunization with NP-CGG in alum, recipients were analyzed to assess the status of the GC response. The percent of GC B cells from group 2 was 2.2-fold lower than groups 1 and 3 (p = 0.04 and p = 0.02, respectively, Figure 8B). Additionally, group 2 recipients had 1.7- and 1.9-fold less TFH cells than groups 1 and 3, respectively (Figure 8C). By contrast, the frequency of CD8+ Treg cells from group 2 was three- and fourfold higher than groups 1 and 3, respectively (Figures 8D,E). Thus, HP-1γ-deficient CD8+ T cells alone have the propensity to reduce the GC response. The results suggest that HP-1γ positively regulates GC and high-affinity Ab responses to T-dependent Ags by curtailing the ability of CD8+ T cells to inhibit an immune response.

Figure 8.

Figure 8

Cbx-3+/− CD8+ T cells directly control the T-dependent immune response. (A) Purified wt or cbx-3+/− spleen and pLN lymphocytes were adoptively transferred into B6-Rag2//recipients: group 1 (control, n = 5) received wt B cells, CD4+ and CD8+ T cells; group 2 (experimental, n = 5) received B cells and CD4+ T cells from wt littermate mice and CD8+ T cells from cbx-3+/− mice; group 3 (control, n = 5) received B cells and CD8+ T cells from wt littermate mice and CD4+ T cells from cbx-3+/− mice. (B,C) On day 10 after NP-CGG in alum immunization, spleens of recipients were analyzed by FACS to determine the frequency of GC (from the B220+gate) and TFH (from the TCRβ+CD4+ gate) populations. (D,E) The frequency of CD122+Ly49+CD8+ Treg cells (from the CD3+ gate) was determined by FACS (E) and plotted (D). Numbers on bottom right corners indicate percent cells. Statistical analysis was performed with GraphPad one-way ANOVA; ns, not significant.

Discussion

The regulation of the adaptive immune response is multilayered, requiring the participation of multiple cells and their proper functions. Here we uncover a novel function for the chromatin-remodeling factor HP-1γ in governing immunity.

Cbx-3 was cloned nearly two decades ago and yet very little is known of its physiological function in the mammalian immune system (30). Our results reveal an essential role for HP-1γ in the control of the adaptive immune response in mice. We demonstrate that HP-1γ has a positive impact on the GC reaction and high-affinity Ab response to T-dependent Ags. Mainly, cbx-3+/− mice fail to mount an effective GC reaction and high-affinity IgG1 Ab response, whereas the low-affinity IgG1 Ab response remains intact. The GC reaction and high-affinity response defects are accompanied by a reduction in the TFH compartment. The fact that neither low-affinity IgG1 Ab nor IgM response is affected in cbx-3+/− mice indicates that HP-1γ may not be essential for extrafollicular reaction. The presence of wild-type HP-1α and HP-1β proteins cannot override defects in GC reaction and high-affinity Ab response seen in cbx-3+/− mice suggests that HP-1γ has a non-redundant regulatory function in immune response to T-dependent Ags. The function of HP-1γ in immune response is not intrinsic to B or TFH cells.

In vitro observations suggest that HP-1γ associates with the silenced κ allele thus may be involved in light chain allelic exclusion during B-cell-development (7). Our results demonstrate that light chain allelic exclusion and B-cell-development in the BM occur normally in cbx-3+/− mice. However, our data do not rule out the possibility that other HP-1 proteins, HP-1α and HP-1β, may compensate for HP-1γ deficiency during B-cell-development.

Recent studies have shown that a subpopulation of effector CD8+ T cells, known as CD8+ Treg cells, control GC reaction and high-affinity Ab response to foreign T-dependent Ags as well as self-Ags by limiting the size of the TFH compartment (27). However, mechanisms that regulate the development or homeostasis of these cells remain elusive. Here, we reveal a novel molecular pathway that controls CD8+ Treg cells in mice after immunization. We show that, through its non-redundant function, HP-1γ limits the size of the CD8+ Treg population thus allowing the immune response to foreign T-dependent Ags to proceed. In mice, HP-1γ deficiency results in the expansion of these cells and reduction of TFH population, which leads to the abrogation of GC reaction and high-affinity Ab response. The level of HP-1γ present in mutant cells is much less than expected despite the presence of one wild-type allele, implying that HP-1γ may also regulate its own expression. HP-1γ deficiency only affects CD8+ T-cell function despite the fact that mutant CD4+ and B cells also express low amounts of HP-1γ, suggesting that in these cells HP-1γ may regulate the expression of genes that are not essential to NP-response.

It remains to be determined how HP-1γ controls the development/homeostasis of CD8+ Treg cells, and if HP-1γ deficiency would alleviate autoimmunity. We speculate that HP-1γ may control the expression and/or function of a transcription factor(s), which governs CD8+ Treg development/homeostasis. HP-1γ does so perhaps by maintaining a chromatin conformation that is unfavorable to the expression and/or function of this putative transcription factor(s). Future genome wide experiments will allow us to map the changing epigenomic landscape in HP-1γ sufficient and deficient CD8+ T cells. These ongoing studies will expand our understanding of mechanisms by which HP-1γ, through its ability to remodel the chromatin, regulates immunity.

In summary, this study shows for the first time that in mice the non-redundant regulatory function of HP-1γ governs GC and high-affinity Ab responses by limiting the pool of CD8+ Treg cells.

Materials and Methods

Mice

cbx-3 mutant mice were generated, as described in Ref. (10, 28). Mice were backcrossed to C57BL/6 for 12 generations. B6-Rag2−/−Cγ−/− and B6.SJL mice were purchased from Taconic. All mice were maintained in specific pathogen-free conditions. All mouse protocols were approved by the BIDMC Institutional Animal Care and Use Committee.

Fluorescence-activated cell sorting

Fluorescence-activated cell sorting was performed on the BD 5-laser LSR II. Analysis was carried with FlowJo software (Tree Star, Inc.). All fluorochrome-conjugated antibodies were purchased from Biolegend or BD Biosciences. The following antibodies were used: ckit-APC (1:200); CD25-PE (1:200); IgM-FITC (1:500); CD8-Pacific blue (1:200); CD8-APC-Cy7 (1:300); CD8-PE-Cy7 (1:200); Ly-49-FITC (1:100); CD44-Pacific blue (1:200); IgD-PE (1:500); CD21-APC (1:200); CD23-PE (1:150); CD19-PE-Cy7 (1:300); B220-Pacific blue (1:300); CD38-APC (1:200); IgG1-FITC (1:50); FAS-PE (1:200); CD4-FITC (1:200); CD4-PE (1:150); TCRβ-Brilliant-Violet 412 (1:200); PD1-PE-Cy7 (1:100); CXCR5-Biotin (1:100); SA-PerCP (1:100); CD45.1-FITC (1:150); CD45.2-PE-Cy7 (1:100); CD45.2-Pacific blue (1:200); CD3-APC (1:200); CD122-Pacific blue (1:200).

T-dependent immune response

Adult mice (7–8-week-old) were immunized with 50 μg of the T-dependent Ag 4-hydroxy-3-nitrophenylacetyl hapten conjugated to chicken gamma globulin (NP-CGG, BioSearch Technologies) per mouse in alum (Thermo Scientific) (ratio 1:1). Immune sera were obtained at days 7 and 14 after immunization. FACS analysis was performed on the same days.

Immunohistochemistry

Immunohistochemistry was performed using 4 μm thick formalin-fixed, paraffin-embedded tissue sections. Briefly, slides were soaked in xylene, passed through graded alcohols, and put in distilled water. Slides were then pre-treated with 1.0-mM EDTA, pH 8.0, or 1.0 mM citrate (Zymed) in a steam pressure cooker (Decloaking Chamber, BioCare Medical) as per manufacturer’s instructions, followed by washing in distilled water. All subsequent steps were performed at room temperature in a hydrated chamber. Slides were pre-treated with Peroxidase Block (DAKO) for 5 min to quench endogenous peroxidase activity, followed by Serum free Protein Block (DAKO) for 20 min. Biotinylated PNA (Vector Laboratories) was applied for 1 h (all diluted in DAKO diluents). Slides were washed in 50 mM Tris–Cl, pH 7.4. Slides were washed again, and detected with anti-streptavidin–HRP Envision + kit (DAKO) as per manufacturer’s instructions. After further washing, immunoperoxidase staining was developed using a DAB chromogen (DAKO) and counterstained with hematoxylin. Images were acquired with the Nikon Eclipse E600 and SPOT Insight four camera and software.

Enzyme-linked immunosorbent assay

Antibody response to NP was determined by ELISA using NP(4)-BSA or NP(25)-BSA (BioSearch Technologies) from days 7 and 14 immune sera. ELISA was performed as described (11).

In vitro B-cell activation and isotype switch assay

MACS-purified (Miltenyi Biotec) CD43 or CD19+ B cells were activated in vitro at a density of 1–3 × 106 cells/ml with 2 μg/ml of anti-CD40 clone HM40-3 (eBiosciences) plus 25 ng/ml of recombinant mouse IL-4 (R&D Systems), 10 μg/ml of goat F(ab′)2 anti-mouse IgM (Jackson Immunoresearch), LPS (20 μg/ml), or LPS + IL-4 (Sigma).

Proliferation assays and analysis

MACS-purified CD43 B cells labeled with CFSE were activated with indicated stimuli as above for 3 or 4 days. Data were analyzed using the proliferation platform of the FlowJo software (Tree Star Inc.).

Generation of bone marrow chimeras

Bone marrow cells from femurs and tibias of 4-week-old B6.SJL mice (CD45.1) were mixed with either 4-week-old cbx3+/− or littermate control mice (CD45.2) at a 1:1 ratio. Mixed BM cells (2 × 106) were injected i.v. into 7-week-old Rag2−/−Cγ−/−recipients. Eight weeks after BM reconstitution, recipients were immunized with NP-CGG in alum (ratio 1:1). Analysis was carried out 14 days after immunization.

Western blots

Purified CD8+CD44 (1 × 106) cells were lysed with radio-immunoprecipitation assay (RIPA) buffer (Boston BioProducts) containing protease inhibitor cocktail (Roche) on ice for 30 min. Cells were centrifuged at 14,000 rpm for 15 min at 4°C. Protein concentration was determined by Bio-Rad Protein Assay Kit (Bio-Rad). Ten micrograms of protein extracts were denatured at 95°C for 10 min, separated by SDS-PAGE, and transferred onto PVDF membranes (EMD Millipore). Membranes were probed with antibodies against HP-1γ (Cell Signaling Technology) or β-actin (Sigma Aldrich). Proteins of interest were detected with HRP-conjugated secondary antibodies and visualized with the Pierce ECL Western blotting substrate (Thermo Scientific).

Adoptive transfer

B, CD8+, and CD4+ cells were prepared from spleen and lymph nodes of 7-week-old cbx3+/− and wt littermate mice as described (18). 2 × 106 wild-type B cells, 1 × 106 wild-type or mutant CD8+, and 1 × 106 wild-type or mutant CD4+ cells were injected i.v. into 7-week-old Rag/Cγ/recipients. The following day, recipients were immunized with NP-CGG in alum (ratio 1:1). Analysis was carried out 10 days after immunization.

Statistical and graph analysis

P values were calculated using one-way ANOVA and graphs were plotted with Prism 6 (GraphPad Software).

Author Contributions

Ngoc Ha, Duc-Hung Pham, and Aliakbar Shahsafaei carried out all experiments; Chie Naruse and Masahide Asano generated the cbx-3 mutant mice and provided advice on their use; To-Ha Thai conceived and directed all research, and along with Ngoc Ha and Duc-Hung Pham prepared the manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Dr. Hye-Jung Kim for advice with CD8+ Treg experiments. We thank Mr. Arturo Contreras at the BIDMC animal facility for help with BM chimera experiments. We also thank Ms. Xue Shui for adoptive transfer experiments. We are grateful to Dr. David Nelson for editing the manuscript. This work was supported by NIH grant AI099012 and the Mayer Family Fund (To-Ha Thai).

References

  • 1.Singh PB, Georgatos SD. HP1: facts, open questions, and speculation. J Struct Biol (2002) 140(1–3):10–6 10.1016/S1047-8477(02)00536-1 [DOI] [PubMed] [Google Scholar]
  • 2.Lomberk G, Wallrath L, Urrutia R. The heterochromatin protein 1 family. Genome Biol (2006) 7(7):228. 10.1186/gb-2006-7-7-228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hediger F, Gasser SM. Heterochromatin protein 1: don’t judge the book by its cover! Curr Opin Genet Dev (2006) 16(2):143–50 10.1016/j.gde.2006.02.013 [DOI] [PubMed] [Google Scholar]
  • 4.Lomberk G, Bensi D, Fernandez-Zapico ME, Urrutia R. Evidence for the existence of an HP1-mediated subcode within the histone code. Nat Cell Biol (2006) 8(4):407–15 10.1038/ncb1383 [DOI] [PubMed] [Google Scholar]
  • 5.Hiragami-Hamada K, Shinmyozu K, Hamada D, Tatsu Y, Uegaki K, Fujiwara S, et al. N-terminal phosphorylation of HP1{alpha} promotes its chromatin binding. Mol Cell Biol (2011) 31(6):1186–200 10.1128/MCB.01012-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Vakoc CR, Mandat SA, Olenchock BA, Blobel GA. Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol Cell (2005) 19(3):381–91 10.1016/j.molcel.2005.06.011 [DOI] [PubMed] [Google Scholar]
  • 7.Goldmit M, Ji Y, Skok J, Roldan E, Jung S, Cedar H, et al. Epigenetic ontogeny of the Igk locus during B cell development. Nat Immunol (2005) 6(2):198–203 10.1038/ni1154 [DOI] [PubMed] [Google Scholar]
  • 8.Mateescu B, Bourachot B, Rachez C, Ogryzko V, Muchardt C. Regulation of an inducible promoter by an HP1beta-HP1gamma switch. EMBO Rep (2008) 9(3):267–72 10.1038/embor.2008.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Minc E, Courvalin JC, Buendia B. HP1gamma associates with euchromatin and heterochromatin in mammalian nuclei and chromosomes. Cytogenet Cell Genet (2000) 90(3–4):279–84 10.1159/000056789 [DOI] [PubMed] [Google Scholar]
  • 10.Takada Y, Naruse C, Costa Y, Shirakawa T, Tachibana M, Sharif J, et al. HP1gamma links histone methylation marks to meiotic synapsis in mice. Development (2011) 138(19):4207–17 10.1242/dev.064444 [DOI] [PubMed] [Google Scholar]
  • 11.Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science (2007) 316(5824):604–8 10.1126/science.1141229 [DOI] [PubMed] [Google Scholar]
  • 12.Coffey F, Alabyev B, Manser T. Initial clonal expansion of germinal center B cells takes place at the perimeter of follicles. Immunity (2009) 30(4):599–609 10.1016/j.immuni.2009.01.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pereira JP, Kelly LM, Cyster JG. Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses. Int Immunol (2010) 22(6):413–9 10.1093/intimm/dxq047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Rajewsky K. Clonal selection and learning in the antibody system. Nature (1996) 381(6585):751–8 10.1038/381751a0 [DOI] [PubMed] [Google Scholar]
  • 15.Kaji T, Ishige A, Hikida M, Taka J, Hijikata A, Kubo M, et al. Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory. J Exp Med (2012) 209(11):2079–97 10.1084/jem.20120127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol (2011) 29:621–63 10.1146/annurev-immunol-031210-101400 [DOI] [PubMed] [Google Scholar]
  • 17.Nutt SL, Tarlinton DM. Germinal center B and follicular helper T cells: siblings, cousins or just good friends? Nat Immunol (2011) 12(6):472–7 10.1038/ni.2019 [DOI] [PubMed] [Google Scholar]
  • 18.Linterman MA, Beaton L, Yu D, Ramiscal RR, Srivastava M, Hogan JJ, et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med (2010) 207(2):353–63 10.1084/jem.20091738 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Vinuesa CG, Cyster JG. How T cells earn the follicular rite of passage. Immunity (2011) 35(5):671–80 10.1016/j.immuni.2011.11.001 [DOI] [PubMed] [Google Scholar]
  • 20.Qi H, Cannons JL, Klauschen F, Schwartzberg PL, Germain RN. SAP-controlled T-B cell interactions underlie germinal centre formation. Nature (2008) 455(7214):764–9 10.1038/nature07345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: lineage and location. Immunity (2009) 30(3):324–35 10.1016/j.immuni.2009.03.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Deenick EK, Chan A, Ma CS, Gatto D, Schwartzberg PL, Brink R, et al. Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling. Immunity (2010) 33(2):241–53 10.1016/j.immuni.2010.07.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Choi YS, Kageyama R, Eto D, Escobar TC, Johnston RJ, Monticelli L, et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity (2011) 34(6):932–46 10.1016/j.immuni.2011.03.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Shulman Z, Gitlin AD, Targ S, Jankovic M, Pasqual G, Nussenzweig MC, et al. T follicular helper cell dynamics in germinal centers. Science (2013) 341(6146):673–7 10.1126/science.1241680 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Noble A, Zhao ZS, Cantor H. Suppression of immune responses by CD8 cells. II. Qa-1 on activated B cells stimulates CD8 cell suppression of T helper 2 responses. J Immunol (1998) 160(2):566–71 [PubMed] [Google Scholar]
  • 26.Kim HJ, Verbinnen B, Tang X, Lu L, Cantor H. Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature (2010) 467(7313):328–32 10.1038/nature09370 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kim HJ, Wang X, Radfar S, Sproule TJ, Roopenian DC, Cantor H. CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc Natl Acad Sci U S A (2011) 108(5):2010–5 10.1073/pnas.1018974108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Naruse C, Fukusumi Y, Kakiuchi D, Asano M. A novel gene trapping for identifying genes expressed under the control of specific transcription factors. Biochem Biophys Res Commun (2007) 361(1):109–15 10.1016/j.bbrc.2007.06.161 [DOI] [PubMed] [Google Scholar]
  • 29.Trowbridge JJ, Sinha AU, Zhu N, Li M, Armstrong SA, Orkin SH. Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains. Genes Dev (2012) 26(4):344–9 10.1101/gad.184341.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Horsley D, Hutchings A, Butcher GW, Singh PB. M32, a murine homologue of Drosophila heterochromatin protein 1 (HP1), localises to euchromatin within interphase nuclei and is largely excluded from constitutive heterochromatin. Cytogenet Cell Genet (1996) 73(4):308–11 10.1159/000134363 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES